Rigel Pharmaceuticals, Inc.RIGLNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Trending lower, below historical average, structural decline.
Left:
||||
Enterprise value to sales ratio
Latest
1.67
↓ 89% below average
Average (9y)
14.70
Historical baseline
Range
High:100.83
Low:1.67
CAGR
-16.0%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 1.67 | -30.4% |
| 2023 | 2.40 | +4.5% |
| 2022 | 2.29 | -26.2% |
| 2021 | 3.11 | -43.7% |
| 2020 | 5.52 | -12.0% |
| 2019 | 6.27 | -4.7% |
| 2018 | 6.58 | -93.5% |
| 2017 | 100.83 | +876.4% |
| 2016 | 10.33 | +29.2% |
| 2015 | 7.99 | - |